4: Tian Z, Zhou D, Jiang R, Zhou B, (2024). Role of AMIGO2 in cancer progression: Novel insights (Review). Oncol Lett 28:434.
Abstract
3: Berico P, Cigrang M, Davidson G, Braun C, Sandoz J, Legras S, Vokshi BH, Slovic N, Peyresaubes F, Gene Robles CM, Egly JM, Compe E, Davidson I, Coin F, (2021). CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma. EMBO Rep 22:e51683.
Abstract
2: Bi O, Anene CA, Nsengimana J, Shelton M, Roberts W, Newton-Bishop J, Boyne JR, (2021). SFPQ promotes an oncogenic transcriptomic state in melanoma. Oncogene 40:5192-5203.
Abstract
1: Fontanals-Cirera B, Hasson D, Vardabasso C, Di Micco R, Agrawal P, Chowdhury A, Gantz M, de Pablos-Aragoneses A, Morgenstern A, Wu P, Filipescu D, Valle-Garcia D, Darvishian F, Roe JS, Davies MA, Vakoc CR, Hernando E, Bernstein E, (2017). Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene. Mol Cell 68:731-744.e9.
Abstract
EMBO Rep (n=1)
Mol Cell (n=1)
Oncogene (n=1)
Oncol Lett (n=1)
2017 (n=1)
2021 (n=2)
2024 (n=1)
Agrawal P(1), Anene CA(1), Berico P(1), Bernstein E(1), Bi O(1), Boyne JR(1), Braun C(1), Chowdhury A(1), Cigrang M(1), Coin F(1), Compe E(1), Darvishian F(1), Davidson G(1), Davidson I(1), Davies MA(1), Di Micco R(1), Egly JM(1), Filipescu D(1), Fontanals-Cirera B(1), Gantz M(1), Gene Robles CM(1), Hasson D(1), Hernando E(1), Jiang R(1), Legras S(1), Morgenstern A(1), Newton-Bishop J(1), Nsengimana J(1), Peyresaubes F(1), Roberts W(1), Roe JS(1), Sandoz J(1), Shelton M(1), Slovic N(1), Tian Z(1), Vakoc CR(1), Valle-Garcia D(1), Vardabasso C(1), Vokshi BH(1), Wu P(1), Zhou B(1), Zhou D(1), de Pablos-Aragoneses A(1),
Antineoplastic Agents(1), Antineoplastic Agents/pharmacology(1), Bromodomain Containing Proteins(1), Carcinogenesis(1), Carcinogenesis/genetics(1), Cell Adhesion Molecules(1), Cell Adhesion Molecules/metabolism(1), Cell Cycle Proteins(1), Cell Line, Tumor(3), Cell Movement(1), Cell Movement/genetics(1), Cell Proliferation(1), Cell Proliferation/genetics(1), Cell Survival(1), Cell Survival/drug effects(1), Drug Tolerance(1), Enhancer Elements, Genetic(1), Epithelial-Mesenchymal Transition(1), Epithelial-Mesenchymal Transition/genetics(1), Female(1), Gene Expression Regulation, Neoplastic(2), Humans(3), Male(1), Melanoma(3), Melanoma/drug therapy(2), Melanoma/drug therapy/genetics(1), Melanoma/drug therapy/genetics/metabolism/pathology(1), Melanoma/genetics(1), Melanoma/genetics/pathology/metabolism(1), MicroRNAs(1), MicroRNAs/genetics(1), Microphthalmia-Associated Transcription Factor(1), Microphthalmia-Associated Transcription Factor/genetics(1), Microphthalmia-Associated Transcription Factor/genetics/metabolism(1), Neoplasm Metastasis(1), Neoplasm Proteins(1), Neoplasm Proteins/metabolism(1), Nerve Tissue Proteins(1), Nerve Tissue Proteins/genetics(1), Nerve Tissue Proteins/genetics/metabolism(1), Nuclear Proteins(1), Nuclear Proteins/genetics(1), Nuclear Proteins/genetics/metabolism(1), PTB-Associated Splicing Factor(1), PTB-Associated Splicing Factor/genetics(1), PTB-Associated Splicing Factor/genetics/metabolism(1), Protein Serine-Threonine Kinases(1), Protein Serine-Threonine Kinases/genetics(1), Protein Serine-Threonine Kinases/genetics/metabolism(1), RNA, Long Noncoding(1), RNA, Long Noncoding/genetics(1), Receptor Protein-Tyrosine Kinases(1), Receptor Protein-Tyrosine Kinases/metabolism(1), Transcription Factors(1), Transcription Factors/genetics(1), Transcription Factors/genetics/metabolism(1), Transcriptome(1), Transcriptome/genetics(1),
This Citation list has been generated on 2026/04/07 by PubReMiner CV Output: PubReMiner